The urokinase-streptokinase pulmonary embolism trial (phase II) results

Circulation. 1974 Dec;50(6):1070-1. doi: 10.1161/01.cir.50.6.1070.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Blood Pressure
  • Cardiac Output
  • Drug Evaluation
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Pulmonary Circulation
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / drug therapy*
  • Pulmonary Embolism / physiopathology
  • Radiography
  • Radionuclide Imaging
  • Streptodornase and Streptokinase / administration & dosage
  • Streptodornase and Streptokinase / therapeutic use*
  • Time Factors
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Urokinase-Type Plasminogen Activator / therapeutic use*
  • Vascular Resistance

Substances

  • Fibrinolytic Agents
  • Streptodornase and Streptokinase
  • Urokinase-Type Plasminogen Activator